Table 5.

Multi-moderator analyses for other outcomes

	Moderator level	d	SE	Z	P	CI
Intercept		1.13	0.17	6.60	< .0001	0.80 to 1.47
Region	UK	Ref
	North America	0.17	0.11	1.59	0.111	− 0.04 to 0.39
	Mainland Europe	0.04	0.12	0.32	0.752	− 0.20 to 0.27
	Asia	0.03	0.27	0.10	0.924	− 0.50 to 0.55
	Australasia	− 0.16	0.31	− 0.49	0.626	− 0.76 to 0.46
Severity	Mild	Ref
	Moderate	− 0.14	0.11	− 1.23	0.220	− 0.36 to 0.08
	Severe	− 0.21	0.14	− 0.12	0.901	− 0.30 to 0.26
	University (mild-to-severe)	0.49	0.17	− 1.25	0.210	− 0.54 to 0.12
Therapy modality	Cognitive-behavioural	Ref
	Psychodynamic	− 0.25	0.11	− 2.23	0.026*	− 0.47 to − 0.03
	Counselling	− 0.16	0.18	− 0.86	0.387	− 0.51 to 0.12
	Other	− 0.39	0.11	− 3.47	0.001*	− 0.60 to − 0.17
Treatment stage	Preliminary studies	Ref
	Routine evaluations	0.06	0.13	0.45	0.650	0.20 to 0.32
Analysis	Includes lost to follow up	Ref
	Completers	0.14	0.09	1.59	0.111	− 0.03 to 0.31
Experience	Qualified staff	Ref
	Trainees	− 0.30	0.16	− 1.90	0.058	− 0.61 to 0.01
Sample size	Large	Ref
	Medium	− 0.01	0.12	− 0.09	0.925	− 0.24 to 0.22
	Small	− 0.06	0.12	− 0.49	0.626	− 0.30 to 0.18
Publication year		0.00	0.01	0.46	0.646	− 0.01 to 0.02
Sample age		− 0.00	0.01	− 0.56	0.576	− 0.02 to 0.01
% Female		− 0.14	0.23	− 0.62	0.534	− 0.59 to 0.31

k = 153, Tau² = 0.24[SE = 0.03], I² = 100%, R² = 21.44%

* = < .05